Medicare

Allowing Medicare to negotiate drug prices is a popular solution to healthcare costs. But it may not work

Allowing Medicare to negotiate drug prices is a popular solution to healthcare costs. But it may not work

At his press conference Wednesday, President-elect Donald Trump endorsed what may be the most oft-cited solution to the crisis of skyrocketing drug prices: allowing Medicare to negotiate prices directly with drug manufacturers. 

Trump’s words were solidly in the mainstream of healthcare reform thought, even if he did add the spin of a self-styled dealmaker. (Democratic candidates Hillary Clinton and Bernie Sanders both advocated the same policy during the campaign.)

Calling for the creation of “new bidding procedures for the drug industry,” Trump charged that drug manufacturers are “getting away with murder.” Big Pharma, he said,...

52°